Jane Reed, Director of Safety & Regulatory at IQVIA NLP will be presenting and Yannis Haldoupis, application scientist, at IQVIA NLP will be exhibiting at the IQVIA booth at the World Drug Safety Congress Europe on October 4th and 5th, 2023 in Amsterdam, Netherland.
Jane Reed will be presenting on October 4th at 5:10pm - Transform your drug safety processes with Natural Language Processing
Pharma organizations are looking for innovations to address the challenge of increasing volumes of safety-related data, and shift the needle from cost to value. Heads of drug safety are exploring technologies such as artificial intelligence (AI) and natural language processing (NLP) to bring efficiency gains. In this presentation, we will discuss how IQVIA NLP can be applied for safety assessment and medical literature monitoring NLP transforms unstructured text into structured data that can be rapidly analyzed or visualized. This enables effective search of literature and other key sources for adverse events and the critical context around these. Use cases from FDA and top pharma will be discussed, to showcase how NLP supports safety processes and decision making.
Get in touch to arrange a meeting or stop by the IQVIA booth 45 to discuss with Jane and Yannis.
